| Nov 14 |
Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt
|
| Nov 13 |
Glucotrack announces pricing of $10M public offering
|
| Nov 13 |
Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering
|
| Oct 22 |
GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE
|
| Oct 1 |
GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING
|
| Sep 23 |
GlucoTrack files for $30M mixed securities shelf
|
| Sep 3 |
JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS
|
| Aug 27 |
GLUCOTRACK ANNOUNCES NEW VICE PRESIDENT OF CLINICAL OPERATIONS
|
| Aug 15 |
Glucotrack’s Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference
|
| Aug 5 |
GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE
|
